Below are the most recent publications written about "Randomized Controlled Trials as Topic" by people in Profiles.
-
Charlson ME, Mittleman I, Ramos R, Cassells A, Lin TJ, Eggleston A, Wells MT, Hollenberg J, Pirraglia P, Winston G, Tobin JN. Preventing "tipping points" in high comorbidity patients: A lifeline from health coaches - rationale, design and methods. Contemp Clin Trials. 2025 May; 152:107865.
-
Liu K, He H, Liu M, Hu YQ, Lu LW, Liu B, Chen JH. Evaluating the differential benefits of varying carbohydrate-restricted diets on lipid profiles and cardiovascular risks in dyslipidemia: a meta-analysis and systematic review. Food Funct. 2025 Feb 03; 16(3):831-852.
-
Ezenna C, Krishna MM, Joseph M, Pereira V, Nadeem S, Valania G, Goldsweig AM. The Efficacy and Safety of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. Am J Cardiol. 2025 Apr 15; 241:52-60.
-
Carson JL, Fergusson DA, Noveck H, Mallick R, Simon T, Rao SV, Cooper H, Stanworth SJ, Portela GT, Ducrocq G, Bertolet M, DeFilippis AP, Goldsweig AM, Kim S, Triulzi DJ, Menegus MA, Abbott JD, Lopes RD, Brooks MM, Alexander JH, H?bert PC, Goodman SG, Steg PG. Restrictive versus Liberal Transfusion in Myocardial Infarction - A Patient-Level Meta-Analysis. NEJM Evid. 2025 Feb; 4(2):EVIDoa2400223.
-
Aimo A, Olivotto I, Todiere G, Barison A, Panichella G, Fiuzat M, Linde C, Lakdawala NK, Desai M, Zannad F, Maron MS. Endpoint Selection in Randomized Clinical Trials for Hypertrophic Cardiomyopathy. JACC Heart Fail. 2025 Feb; 13(2):200-212.
-
Sellinger JJ, Rosen MI, Lazar CM, Gilstad-Hayden K, Dziura J, Li FY, Mattocks K, Weede A, Sullivan-Tibbs M, Rose L, Garcia Vassallo G, Manhapra A, Turner A, Vogt D, Woodward EN, Hartmann CW, Haskell SG, Mohammad A, Martino S. Screening, brief intervention, and referral to treatment for pain management for veterans separating from military service: study protocol of a hybrid type 2 study testing implementation facilitation versus training-as-usual. Pain Med. 2024 Nov 01; 25(Supplement_1):S99-S106.
-
Howard-Wilson S, Ching J, Gentile S, Ho M, Garcia A, Ayturk D, Lazar P, Hammerquist N, McManus D, Barton B, Bird S, Moore J, Soni A. Efficacy of a Multimodal Digital Behavior Change Intervention on Lifestyle Behavior, Cardiometabolic Biomarkers, and Medical Expenditure: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2024 Oct 30; 13:e50378.
-
Long MT, Krause BM, de Jong A, Dollerschell JT, Brewer JM, Casey JD, Gaillard JP, Gandotra S, Ghamande SA, Gibbs KW, Ginde AA, Hughes CG, Janz DR, Khan A, Latimer A, Mitchell S, Page DB, Russell DW, Self WH, Semler MW, Stempek S, Trent S, Vonderhaar DJ, West JR, Halliday SJ. Diabetes Mellitus Is Not a Risk Factor for Difficult Intubation Among Critically Ill Adults: A Secondary Analysis of Multicenter Trials. Crit Care Med. 2025 Jan 01; 53(1):e65-e73.
-
Dong G, Cui Y, Gamalo-Siebers M, Liao R, Liu D, Hoaglin DC, Lu Y. On approximate equality of Z-values of the statistical tests for win statistics (win ratio, win odds, and net benefit). J Biopharm Stat. 2025 May; 35(3):457-464.
-
Crowley C, Salciccioli J, Pocock H, Moskowitz A. Manual mastery vs. mechanized magic: current opinions on manual vs. mechanical chest compressions. Curr Opin Crit Care. 2024 Dec 01; 30(6):597-602.